A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression

SirishSanaka; George RKasarala; Hans LTillmann

首页> 外文期刊>The Journal of Infectious Diseases >A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression

【24h】

A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression

机译：丙型肝炎病毒治愈的缺点？对乙型肝炎病毒再激活，器官排斥或肝细胞癌进展需要警惕

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hepatitis C virus (HCV) infection can be cured in almost every patient. We believe there should not be any hesitation to treat HCV, but there are 3 areas needing some awareness: history of organ transplantation, hepatocellular carcinoma, or previous exposure to hepatitis B virus.

机译：丙型肝炎病毒（HCV）感染可能在几乎所有患者中都可以治愈。我们认为不应该犹豫要治疗HCV，但有3个区域需要一些意识：器官移植，肝细胞癌或之前暴露于乙型肝炎病毒的历史。

著录项

来源
《The Journal of Infectious Diseases》 |2018年第6期|共4页
作者
SirishSanaka; George RKasarala; Hans LTillmann;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
HCV; HBV reactivation; rejection; HCC;

机译：HCV;HBV再激活;拒绝;HCC;

相似文献

外文文献
中文文献
专利

1. A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression [J] . SirishSanaka, George RKasarala, Hans LTillmann The Journal of Infectious Diseases . 2018,第6期

机译：丙型肝炎病毒治愈的缺点？对乙型肝炎病毒再激活，器官排斥或肝细胞癌进展需要警惕
2. Prognosis of Patients with Non-hepatitis B virus-, Non-hepatitis C virus-related Hepatocellular Carcinoma: A Comparison with Hepatitis C virus-related Hepatocellular Carcinoma Patients [J] . Noda Yu, Kawaguchi Takumi, Nakano Masahito, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：非乙型肝炎病毒，非丙型肝炎病毒相关肝细胞癌患者的预后：与丙型肝炎病毒相关肝细胞癌患者的比较
3. The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B?virus DNA level [J] . Wenbo Shao, Fengjuan Zhang, Ning Cong, Therapeutics and Clinical Risk Management . 2015,第5期

机译：血清乙型肝炎病毒DNA水平低的中国肝癌患者经动脉化疗栓塞后乙型肝炎病毒的重新激活
4. Herbal Medicine Containing Aristolochic Acid and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection: A Nationwide Population-Based Cohort Study in Taiwan [C] . Wen-Chao Ho, Chi-Jen Chen, Yao-Hsu Yang, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险：台湾全国性人群研究
5. Defining the Oncogenic Functions of Hepatitis B Virus-Human Fusion Transcripts in Hepatocellular Carcinoma. [D] . Lau, Chi Chiu. 2011

机译：定义乙型肝炎病毒-人类融合转录本在肝细胞癌中的致癌作用。
6. Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels 500 copies/mL [O] . Zhi-Bo Xie, Xiao-Bo Wang, De-Liang Fu, 2016

机译：乙型肝炎病毒DNA水平500拷贝/ mL的乙型肝炎病毒相关肝细胞癌患者术后乙型肝炎病毒再激活
7. Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen [O] . Hung Hung-Hsu, Su Chien-Wei, Wu Jaw-Ching, 2010

机译：一名患有乙型肝炎表面抗原阴性的患者经肝动脉栓塞化疗后肝细胞癌中乙型肝炎病毒的再激活
8. Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B e Antigen, and Hepatitis B DNA. [R] . Sjogren, M. H., Dusheiko, G. M., Kew, M. C., 1988

机译：乙型肝炎病毒感染和肝细胞癌：乙型肝炎核心抗原，乙型肝炎抗原和乙型肝炎DNa的Igm抗体之间的相关性。

A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression

摘要

著录项

相似文献

相关主题

期刊订阅